Sciton

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Sciton sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials 1 currently recruiting 11 completed top decile by trial count

Sciton: 12 sponsored US clinical trials, 1 recruiting.

Sciton sponsors 12 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 11 completed. The most-studied condition in this pipeline is Chronic UTI, with 1 trials.

Top-decile sponsor footprint

Sciton ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

11 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

12 total, page 1 of 1

RECRUITING NA

Evaluation of Fractional Ablative Laser Treatment for Skin Conditions

NCT05750901
COMPLETED NA

Evaluation of Broadband Light Treatment for Solar Lentigines

NCT06363240
COMPLETED NA

Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study

NCT05662592
COMPLETED NA

Evaluation of Broadband Light Treatment for Pigmented Skin Lesions

NCT05750914
COMPLETED NA

Laser Treatment of Basal Cell Carcinoma

NCT04936932
COMPLETED NA

Pilot Evaluation of Smart vs HERO Broadband Light Treatment for Pigmented Skin Lesions

NCT04936919
COMPLETED NA

Hybrid Fractional Laser for Treatment of Off Face Body Skin Quality

NCT03969485
COMPLETED NA

Pilot Evaluation of Thulium Laser Alone or in Combination With Broad Band Light for Treatment of Dermatologic Conditions

NCT03944278
COMPLETED NA

Safety and Efficacy of Broad Band Light In Motion Treatment

NCT03970317
COMPLETED NA

Randomized, Controlled Trial With Hybrid Fractional Laser

NCT03647189
COMPLETED NA

Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause

NCT03178825
COMPLETED NA

Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence

NCT03180372

Therapeutic Areas

Chronic UTI 1
Vaginal Dryness 1
Vaginal Atrophy 1
Skin Laxity 1
Dyspareunia 1
Sexual Dysfunction 1
Pigmentation 1

What is open in the Sciton pipeline

1 recruiting of 12 indexed (8% open); 11 completed (92%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Chronic UTI (1 trial), 6 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Sciton: open-pipeline peers nationwide

Peers matched on 12 registered trials and 8% open enrollment, not the therapeutic-area sidebar.

Sciton sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 10152025 0%5%10%15%20% Total trials Recruiting share ScitonAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsAcrotech BiopharmaAtlanta VA Medical CenterBeacon TherapeuticsBoston VA Research Institute
Sciton sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Sciton sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 trials (± recruiting share)

Sponsors near 8% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Sciton page

12 registered trials is a research-attention snapshot, not an endorsement of Sciton or any single study.

  • 1 of Sciton's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Chronic UTI is the condition Sciton studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic UTI trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Sciton pipeline card: 12 registered trials from official public datasets.Report a data error.